EVERSANA Launches Chronic Disease Real-World Data Solution Covering More Than 80 Million Deidentified Patients to Drive Regulatory-Grade Clinical Research and Improve Patient Outcomes
Share this article Share this article CHICAGO, Feb. 25, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today unveiled its comprehensive data, technology and services solution to bring the power of real-world data to chronic disease research, evidence generation and patient support. Through the ACTICS by EVERSANA technology platform, paired with robust outsourced service capabilities in value and evidence research and patient hub services, EVERSANA's Chronic Disease Real-World Data (RWD) solution enables life sciences...
Source: prnewswire.com